135 related articles for article (PubMed ID: 10780068)
21. Chondroradionecrosis of larynx following radiotherapy for metastatic neck disease originating from oral carcinoma.
Bekiroglu F; Wright S; Grew N
Int J Oral Maxillofac Surg; 2007 May; 36(5):459-61. PubMed ID: 17145167
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapeutic management of laryngeal carcinoma.
Hristov B; Bajaj GK
Otolaryngol Clin North Am; 2008 Aug; 41(4):715-40, vi. PubMed ID: 18570955
[TBL] [Abstract][Full Text] [Related]
23. [Sparing normal oral tissues with individual dental stent in radiotherapy for primary nasopharyngeal carcinoma patients].
Qin WJ; Luo W; Lin SR; Sun Y; Li FM; Liu XQ; Ma J; Lu TX
Ai Zheng; 2007 Mar; 26(3):285-9. PubMed ID: 17355792
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukemia following radiotherapy for carcinoma of the cervix: report of a case and brief review of the literature.
Ural AU; Beyzadeoglu M; Avcu F; Nevruz O
Am J Hematol; 2007 May; 82(5):415-6. PubMed ID: 17133425
[No Abstract] [Full Text] [Related]
25. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment.
Lin CS; Jen YM; Cheng MF; Lin YS; Su WF; Hwang JM; Chang LP; Chao HL; Liu DW; Lin HY; Shum WY
Head Neck; 2006 Feb; 28(2):150-7. PubMed ID: 16200628
[TBL] [Abstract][Full Text] [Related]
26. [Side effect of oncological treatment in skin and adnexae].
Haagen J; Hartmann JT; Schmidt M; Ugurel S; Ulrich J; Dörr W
MMW Fortschr Med; 2010 Nov; 152(46):34-6. PubMed ID: 21229721
[No Abstract] [Full Text] [Related]
27. The head and neck radiation oncology patient.
Huber MA; Terezhalmy GT
Quintessence Int; 2003 Oct; 34(9):693-717. PubMed ID: 14982224
[TBL] [Abstract][Full Text] [Related]
28. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
Rosenthal DI; Blanco AI
Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
[TBL] [Abstract][Full Text] [Related]
30. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
Sanguineti G; Endres EJ; Gunn BG; Parker B
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):931-8. PubMed ID: 17011465
[TBL] [Abstract][Full Text] [Related]
31. Individual skin care during radiation therapy.
Zimmermann JS; Budach W; Dörr W
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():74-7. PubMed ID: 9830463
[TBL] [Abstract][Full Text] [Related]
32. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
Langendijk JA; Doornaert P; Rietveld DH; Verdonck-de Leeuw IM; Leemans CR; Slotman BJ
Radiother Oncol; 2009 Feb; 90(2):189-95. PubMed ID: 19167120
[TBL] [Abstract][Full Text] [Related]
33. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck.
Wilson WR; Siegel RS; Harisiadis LA; Davis DO; Nguyen HH; Bank WO
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):809-12. PubMed ID: 11448355
[TBL] [Abstract][Full Text] [Related]
34. Present status of the time factor in clinical radiotherapy. I. The historical background of the recovery exponents.
Fletcher GH; Barkley HT
J Radiol Electrol Med Nucl; 1974; 55(6-7):443-50. PubMed ID: 4419735
[No Abstract] [Full Text] [Related]
35. Failure of hand growth after x-ray therapy.
Goh YS; Khor TH
Singapore Med J; 1973 Mar; 14(1):19-22. PubMed ID: 4713013
[No Abstract] [Full Text] [Related]
36. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.
Waldron J; Warde P; Irish J; Pintilie M; Sellmann S; Bayley A; Cummings B; Kim J; Liu FF; Payne D; Ringash J; Brown D; Freeman J; Gilbert R; Gullane P; Witterick I; O'Sullivan B
Radiother Oncol; 2008 May; 87(2):173-80. PubMed ID: 18342965
[TBL] [Abstract][Full Text] [Related]
37. [Local reactions of the oral and pharyngeal mucosa in the radiation therapy and chemotherapy of head and neck tumors].
Borisevich NV
Med Radiol (Mosk); 1979 Feb; 24(2):39-44. PubMed ID: 423727
[No Abstract] [Full Text] [Related]
38. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
[TBL] [Abstract][Full Text] [Related]
39. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
40. Late complications of radiotherapy for nasopharyngeal carcinoma.
Sumitsawan Y; Chaiyasate S; Chitapanarux I; Anansuthiwara M; Roongrotwattanasiri K; Vaseenon V; Tooncam H
Auris Nasus Larynx; 2009 Apr; 36(2):205-9. PubMed ID: 18635325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
